Analysis for CTVA

📈 Growth & Financial Trajectory

Over the 8 quarters from 2024 Q2 to 2026 Q1, Corteva's revenue started at $6.112B and ended at $4.905B, a decline of about 19%. Net income fell from about $1.056B in 2024 Q2 to $0.723B in 2026 Q1, though a mid-period peak of about $1.316B occurred in 2025 Q2, before retreating. The 8-quarter pattern shows pronounced volatility driven by mix shifts across crops and geographies.

💰 Margins & Cash Flow

Gross margins ranged widely: about 52% in 2026 Q1 (gross profit 2.533B on 4.905B revenue), with quarters in the 28%–42% span elsewhere. Operating margins mirrored this volatility, positive in several quarters but negative in 2025 Q4. Cash flow from operating activities was positive in earlier quarters but negative in 2026 Q1, with net cash flow also negative due to investing and financing outflows; 2024 Q2 posted positive operating cash flow around $0.451B.

🛡️ Balance Sheet & Liquidity

Total assets run around $41–43B with equity near $24–25B; liabilities hover around $18–19B, implying a solid asset base and moderate leverage. Current assets exceed current liabilities in observed quarters, yielding liquidity ratios roughly 1.4–1.7. Debt to equity remains below 1, signaling reasonable balance sheet resilience.

⚠️ Key Drivers & Risks

• Drivers: agricultural input demand and crop protection product demand; global farming activity and crop yields.
• Risks: cyclicality of ag inputs, commodity price volatility, currency/regulatory exposure.